MedPath

Cefotetan

Rx only

Approved
Approval ID

33b13b93-58ce-44c7-b9a2-af3b3a333f80

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Apr 12, 2019

Manufacturers
FDA

Hikma Pharmaceuticals USA Inc.

DUNS: 001230762

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Cefotetan

PRODUCT DETAILS

NDC Product Code0143-9671
Application NumberANDA091031
Marketing CategoryC73584
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateApril 12, 2019
Generic NameCefotetan

INGREDIENTS (2)

SODIUMInactive
Code: 9NEZ333N27
Classification: IACT
CEFOTETANActive
Quantity: 2 g in 1 1
Code: 48SPP0PA9Q
Classification: ACTIB

Cefotetan

PRODUCT DETAILS

NDC Product Code0143-9670
Application NumberANDA091031
Marketing CategoryC73584
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateApril 12, 2019
Generic NameCefotetan

INGREDIENTS (2)

CEFOTETANActive
Quantity: 1 g in 1 1
Code: 48SPP0PA9Q
Classification: ACTIB
SODIUMInactive
Code: 9NEZ333N27
Classification: IACT
© Copyright 2025. All Rights Reserved by MedPath
Cefotetan - FDA Approval | MedPath